With CVS re-establishing forward guidance and offering a deeply discounted valuation, the balance of risk favors upside.
Get this delivered to your inbox, and more info about our products and services.
Chart strategist Katie Stockton breaks down the technical backdrop in CVS.
Advanced Micro Devices and CVS Health are two stocks that recovered in 2025 and could still have more room to run higher.
UBS analyst Kevin Caliendo's revised price target implies 15% upside ahead for shares of the health care benefit and pharmacy…
The results signal steady progress in the health-care giant's aggressive turnaround plan under CEO David Joyner, who stepped into…
The company hit an all-time high earlier in December, and the stock is up more than 19% — outpacing the S&P 500's 17% advance.
CNBC's Jim Cramer said he's optimistic about CVS and explained to investors why he the healthcare company's stock is worth buying
